Peppy is a technology company.
Peppy is an employee healthcare benefit that gives people unlimited, easy access to specialist clinicians across key life stages, all through an app.
Peppy has raised $56.4M across 4 funding rounds.
Peppy has raised $56.4M in total across 4 funding rounds.
Peppy has raised $56.4M in total across 4 funding rounds.
Peppy's investors include Albion VC, Cherry Ventures, EQT Ventures, Felix Capital, FJ Labs, Seaya Ventures, Seedcamp, Chris Murphy, Jarno Vanhatapio.
Peppy is a London-based digital health platform providing specialized employee wellness benefits focused on underserved areas like menopause, fertility, endometriosis, PCOS, pregnancy, early parenthood, and men's health.[1][3][4][5] It connects enterprises' employees to human clinical experts via one-on-one consultations, at-home testing, on-demand resources, and live events, aiming to boost wellness and productivity.[1][3] Serving primarily as an employer benefit, Peppy solves access gaps in gender-specific care, with strong growth including a $45M Series B in 2023 for U.S. and U.K. expansion, product development, and tech enhancements.[5]
Peppy was founded in 2018 by co-founders and co-CEOs Evan Harris and Mridula Pore, alongside Max Landry, drawing from their experiences in startups, healthcare, and consultancies.[1][3][5] Initially conceived to help users find niche health coaches like swimming or running experts—stemming from Harris's passion for functional medicine, longevity care, continuous glucose monitoring, and preventive health—the pivot came in 2019 with the launch of its first enterprise menopause benefit, which broke taboos and drove rapid traction.[3] This success led to expansions into fertility, women's health, and men's health, establishing Peppy as a leader in inclusive employer healthcare in the U.K. and beyond.[3][4]
Peppy rides the wave of employer-sponsored health tech, capitalizing on post-pandemic demands for holistic wellness benefits amid talent shortages and rising healthcare costs.[3][4][5] Timing aligns with growing U.S./U.K. awareness of menopause and fertility challenges—once taboos—fueled by cultural shifts, advocacy, and data showing productivity losses from untreated conditions.[3][5] Market tailwinds include digital health funding resurgence and AI integration for personalized care, positioning Peppy to influence ecosystems by normalizing specialist support in workplaces, much like how mental health apps reshaped benefits.[3][5] It sets a benchmark for inclusive, preventive HealthTech amid broader trends in longevity and functional medicine.[3]
Peppy's trajectory points to U.S. dominance, with AI rollout in early 2025 enabling predictive, scalable benefits that could redefine enterprise wellness.[3][5] Trends like AI-driven triage, expanded gender health awareness, and hybrid work's emphasis on retention will propel growth, potentially capturing share from fragmented competitors. Its influence may evolve from U.K. pioneer to global standard-setter, humanizing niche care while delivering measurable ROI—transforming "embarrassingly bad" benefits landscapes, as co-founder Harris notes.[3] This positions Peppy as a high-momentum bet in HealthTech's preventive shift.
Peppy has raised $56.4M across 4 funding rounds. Most recently, it raised $45.0M Series B in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2023 | $45.0M Series B | Albion VC, Cherry Ventures, EQT Ventures, Felix Capital, FJ Labs, Seaya Ventures, Seedcamp, Chris Murphy, Jarno Vanhatapio | |
| Jul 1, 2021 | $9.0M Series A | Cherry Ventures, Seedcamp, Chris Murphy | |
| Jun 1, 2020 | $2.0M Seed | Cherry Ventures, Seedcamp, Chris Murphy | |
| May 1, 2019 | $380K Seed | Cherry Ventures, Seedcamp, Chris Murphy |